Methylindoles and methoxyindoles are agonists and antagonists of human aryl hydrocarbon receptor

Martina Stepankova, Iveta Bartonkova, Eva Jiskrova, Radim Vrzal, Sridhar Mani, Sandhya Kortagere, Zdenek Dvorak

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134%), 6-Me-indole (91%), and 7-MeO-indole (80%), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 mM), 2,3-diMe-indole (IC50; 11 mM), and 2,3,7-triMe-indole (IC50; 12 mM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.

Original languageEnglish (US)
Pages (from-to)631-644
Number of pages14
JournalMolecular Pharmacology
Volume93
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Aryl Hydrocarbon Receptors
Inhibitory Concentration 50
Cytochrome P-450 CYP1A1
Reporter Genes
indole
human AHR protein
Ligands
Indoles
Dioxins
Chromatin Immunoprecipitation
Xenobiotics
Cytoplasmic and Nuclear Receptors
Reverse Transcription
Immunohistochemistry
Polymerase Chain Reaction
Messenger RNA

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Stepankova, M., Bartonkova, I., Jiskrova, E., Vrzal, R., Mani, S., Kortagere, S., & Dvorak, Z. (2018). Methylindoles and methoxyindoles are agonists and antagonists of human aryl hydrocarbon receptor. Molecular Pharmacology, 93(6), 631-644. https://doi.org/10.1124/mol.118.112151

Methylindoles and methoxyindoles are agonists and antagonists of human aryl hydrocarbon receptor. / Stepankova, Martina; Bartonkova, Iveta; Jiskrova, Eva; Vrzal, Radim; Mani, Sridhar; Kortagere, Sandhya; Dvorak, Zdenek.

In: Molecular Pharmacology, Vol. 93, No. 6, 01.06.2018, p. 631-644.

Research output: Contribution to journalArticle

Stepankova, M, Bartonkova, I, Jiskrova, E, Vrzal, R, Mani, S, Kortagere, S & Dvorak, Z 2018, 'Methylindoles and methoxyindoles are agonists and antagonists of human aryl hydrocarbon receptor', Molecular Pharmacology, vol. 93, no. 6, pp. 631-644. https://doi.org/10.1124/mol.118.112151
Stepankova, Martina ; Bartonkova, Iveta ; Jiskrova, Eva ; Vrzal, Radim ; Mani, Sridhar ; Kortagere, Sandhya ; Dvorak, Zdenek. / Methylindoles and methoxyindoles are agonists and antagonists of human aryl hydrocarbon receptor. In: Molecular Pharmacology. 2018 ; Vol. 93, No. 6. pp. 631-644.
@article{28465332a56c4d629f47cf21d03cb031,
title = "Methylindoles and methoxyindoles are agonists and antagonists of human aryl hydrocarbon receptor",
abstract = "Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134{\%}), 6-Me-indole (91{\%}), and 7-MeO-indole (80{\%}), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 mM), 2,3-diMe-indole (IC50; 11 mM), and 2,3,7-triMe-indole (IC50; 12 mM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.",
author = "Martina Stepankova and Iveta Bartonkova and Eva Jiskrova and Radim Vrzal and Sridhar Mani and Sandhya Kortagere and Zdenek Dvorak",
year = "2018",
month = "6",
day = "1",
doi = "10.1124/mol.118.112151",
language = "English (US)",
volume = "93",
pages = "631--644",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

TY - JOUR

T1 - Methylindoles and methoxyindoles are agonists and antagonists of human aryl hydrocarbon receptor

AU - Stepankova, Martina

AU - Bartonkova, Iveta

AU - Jiskrova, Eva

AU - Vrzal, Radim

AU - Mani, Sridhar

AU - Kortagere, Sandhya

AU - Dvorak, Zdenek

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134%), 6-Me-indole (91%), and 7-MeO-indole (80%), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 mM), 2,3-diMe-indole (IC50; 11 mM), and 2,3,7-triMe-indole (IC50; 12 mM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.

AB - Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134%), 6-Me-indole (91%), and 7-MeO-indole (80%), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 mM), 2,3-diMe-indole (IC50; 11 mM), and 2,3,7-triMe-indole (IC50; 12 mM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.

UR - http://www.scopus.com/inward/record.url?scp=85052989368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052989368&partnerID=8YFLogxK

U2 - 10.1124/mol.118.112151

DO - 10.1124/mol.118.112151

M3 - Article

VL - 93

SP - 631

EP - 644

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 6

ER -